Combination treatment improves treatment for people with relapsed myeloma

New results from the MajesTEC-3 study show that combining teclistamab with daratumumab could help people with myeloma whose cancer has come back or hasn’t responded to previous treatment, to live longer without their cancer getting worse.

New study strengthens evidence for new CAR T-cell treatment for aggressive blood cancer

The scientists tested a new treatment called BE-CAR7, which uses gene editing to change donor immune cells so they can find and destroy cancer.

Blood cancer is Scotland’s third biggest cancer killer taking more than 1,100 lives in a year

Blood Cancer UK’s new manifesto for Scotland, launched ahead of the 2026 Scottish Parliament elections, warns that blood cancer takes over 1,100 lives a year in Scotland. It also warns that 128,000 potential years of life from people in Scotland have been lost over a decade.